Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/1999

Content (14 Articles)

Immunohistochemical expression of internal and external ErbB‐2 domains in invasive breast cancer

Claudio Ceccarelli, Donatella Santini, Michela Gamberini, Mario Taffurelli, Pasquale Chieco, Simonetta Piana, Stefano Pileri, Domenico Marrano

Survival from contralateral breast cancer

C.K. Gajalakshmi, V. Shanta, M. Hakama

Bone marrow micrometastases in breast cancer patients

Annamaria Molino, Giuseppe Pelosi, Rocco Micciolo, Monica Turazza, Rolando Nortilli, Flavia Pavanel, Gian Luigi Cetto

Prevention of rat mammary carcinoma utilizing leuprolide as an equivalent to oophorectomy

Elizabeth A. Jett, Megan R. Lerner, Stan A. Lightfoot, Jay S. Hanas, Daniel J. Brackett, Alan B. Hollingsworth

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

E. Esteban, A.J. Lacave, J.L. Fernández, N. Corral, J.M. Buesa, E. Estrada, I. Palacio, J.M. Vieitez, I. Muñiz, E. Alvarez

Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

Philippe Broët, Susan M Scholl, Anne de la Rochefordière, Alain Fourquet, Thierry Moreau, Yann De Rycke, Bernard Asselain, Pierre Pouillart

Balance of cell proliferation and apoptosis in breast carcinogenesis

Ellen CM Mommers, Paul J van Diest, Angelique M Leonhart, Chris JLM Meijer, Jan PA Baak

Research potential of a unique xenograft model of human proliferative breast disease

Gloria H. Heppner, Sandra R. Wolman, Jeffrey Rosen, David Salomon, Gil Smith, Suresh Mohla

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine